UMEWF Depositi SEC - UMeWorld Limited- Relazione annuale, dichiarazione di delega, prospetto informativo

Statistiche di base

CIK

1114936

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to UMeWorld Limited

SEC Filings (Chronological Order)

Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.

January 14, 2025	EX-13.2	Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
January 14, 2025	EX-13.1	Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
January 14, 2025	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE
January 14, 2025	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
January 14, 2025	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 31, 2024	EX-13.2	Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
January 31, 2024	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
January 31, 2024	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE
January 31, 2024	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 31, 2024	EX-13.1	Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
October 12, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 000-030813 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 66 West Flagler Street, 9th Floor Miami, Florida 33130 (Address of principal execut
October 12, 2023	EX-99.1	2 EXHIBIT 99.1 UMeWorld Limited Executing Key Acquisition Corporate Actions MIAMI, October 10 (GLOBE NEWSWIRE) - UMeWorld Limited (OTC: UMEWF), a vertically integrated edible oil company, is announcing a majority shareholder and directors resolution for the approval of two key corporate actions, outlined below, undertaken with a view to furthering recently publicized acquisitions. UMeWorld will enga
April 19, 2023	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
April 19, 2023	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
April 19, 2023	EX-13.2	Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
April 19, 2023	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES A
April 19, 2023	EX-13.1	Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
January 30, 2023	NT 20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b–25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b–25 SEC FILE NUMBER 000-30813 NOTIFICATION OF LATE FILING CUSIP NUMBER G9160X107 Check One: ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tran
December 19, 2022	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this Amendment No. 2 to the annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state
December 19, 2022	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this Amendment No. 2 to the annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta
December 19, 2022	20-F/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 2) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SEC
November 3, 2022	CORRESP	Year Ended September 30, 2021 CORRESP 1 filename1.htm November 3, 2022 VIA EDGAR Mr. Joseph Kempf Ms. Inessa Kessman Division of Corporation Finance Office of Technology Securities and Exchange Commission 100 F Street, NE, Washington, D.C. 20549 Re: UMeWorld Limited Amended Form 20-F for the year ended September 30, 2021 Filed February 17, 2022 File No. 000-30813 Dear Mr. Kempf and Ms. Kessman; This letter is being furnished i
September 26, 2022	EX-99.1	UMeWorld Limited Dissolves the VIE Structure, Winds Down Its Educational Business in China EXHIBIT 99.1 UMeWorld Limited Dissolves the VIE Structure, Winds Down Its Educational Business in China The Company is transitioning itself into a health and wellness company through its wholly-owned U.S. subsidiary Dagola Inc. Hong Kong, September 26, 2022 – UMeWorld Limited (OTC PINK: UMEWF) today announced that the Company’s wholly-owned Chinese subsidiary, UMeLook (Guangzhou) Information Techn
September 26, 2022	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 000-0308 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) Unit 12B, Hang Seng Causeway Bay Building 28 Yee Wo Street, Causeway Bay Hong Kon
February 17, 2022	EX-12.1	Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F/A, as amended by Amendment No. 1 thereto, of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessar
February 17, 2022	20-F/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A (Amendment No. 1) (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
February 17, 2022	EX-13.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2021 as filed with the Securities and Exchange Commission on February 14, 2022, as amended by Amendment No. 1 thereto (the “Report”), I, Winfield Ding, Chief Fin
February 17, 2022	EX-12.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F, as amended by Amendment No. 1 thereto, of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessar
February 17, 2022	EX-13.1	Certification by Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2021 as filed with the Securities and Exchange Commission on February 14, 2022, as amended by Amendment No. 1 thereto (the “Report”), I, Michael Lee, Chief Execu
February 14, 2022	EX-13.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
February 14, 2022	EX-12.1	Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
February 14, 2022	EX-13.1	Certification by Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
February 14, 2022	EX-12.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
February 14, 2022	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES A
January 31, 2022	NT 20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b–25 NT 20-F 1 umewfnt20f.htm NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b–25 SEC FILE NUMBER 000-30813 CUSIP NUMBER G9160X107 NOTIFICATION OF LATE FILING Check One: ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Tran
September 27, 2021	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES A
September 27, 2021	EX-13.1	Certification by Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the ?Company?) on Form 20-F for the year ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
September 27, 2021	EX-12.1	Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
September 27, 2021	EX-12.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
September 27, 2021	EX-13.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
July 16, 2021	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2019 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES A
July 16, 2021	EX-12.1	Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
July 16, 2021	EX-12.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
July 16, 2021	EX-13.1	Certification by Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the ?Company?) on Form 20-F for the year ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
July 16, 2021	EX-13.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the ?Company?) on Form 20-F for the year ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
June 4, 2021	EX-12.1	Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
June 4, 2021	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2018 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES A
June 4, 2021	EX-13.2	Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
June 4, 2021	EX-13.1	Certification by Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the ?Company?) on Form 20-F for the year ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
June 4, 2021	EX-12.2	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
April 16, 2021	6-K	Current Report of Foreign Issuer - FORM 6-K 6-K 1 umewf6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2021 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) Unit 12B, Hang Seng Causeway Bay Building 28 Yee Wo Stree
June 24, 2020	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2020 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) Unit 12B, Hang Seng Causeway Bay Building 28 Yee Wo Street, Causeway Bay Hong Kong, C
June 24, 2020	EX-16.1	Letter from MaloneBailey, LLP addressed to the U.S. Securities and Exchange Commission EXHIBIT 16.1 June 24, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Ladies and Gentlemen: We have read the statements made by UMeWorld Limited under the caption “Changes in Company's Certifying Accountant” included in this Form 6-K for the event that occurred on June 23, 2020. We are in agreement with the statements contained therein as much as they relate to ou
February 1, 2019	NT 20-F	UMEWF / UMeWorld Limited NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File No. 000-30813 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K x Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on
April 11, 2018	EX-12.2	Certification of Interim C.F.O. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Winfield Ding, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
April 11, 2018	20-F	UMEWF / UMeWorld Limited FORM 20-F 20-F 1 umewf20f.htm FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2017 OR ¨ Transition Report Pursuant to Section 1
April 11, 2018	EX-12.1	Certification of C.E.O. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. umewf_ex121.htm EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that:
April 11, 2018	EX-13.1	Certification of Michael Lee pursuant to Section 1350 of Chapter 63 of Title 18 United States Code. EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
April 11, 2018	EX-13.2	Certification of Michael Lee pursuant to Section 1350 of Chapter 63 of Title 18 United States Code. EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Winfield Ding, Chief Financial Officer of the Company, certify, p
January 26, 2018	NT 20-F	UMEWF / UMeWorld Limited NT 20-F umewfnt20f.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File No. 000-30813 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K x Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transi
November 6, 2017	6-K	UMEWF / UMeWorld Limited FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2017 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) Suite 1504, 15/F, Island Centre 1 Great George Street Causeway Bay, H
July 21, 2017	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2017 AND SEPTEMBER 30, 2016 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2017 AND SEPTEMBER 30, 2016 (Unaudited) (All amounts in US Dollars) June 30, September 30, 2017 2016 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 15,515 $ 46,301 Accounts Receivable 232 265 Deposit 8,433 8,749 Prepayment 67,862 27,472 TOTAL CURRENT ASSETS 92,042 82,787 NON-CURRENT AS
July 21, 2017	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2017 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) Suite 1504, 15/F, ISLAND CENTRE, 1 GREAT GEORGE STREET, CAUSEWAY BAY HONG
July 21, 2017	EX-99.2	Jun 30 umewfex992.htm EXHIBIT 99.2 THIRD QUARTER 2017 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company?s K-12 flagship product, is a cloud-based, adaptive learning and assessment platform that can intelligently analyze and adapt to a student?s performance and personalizes the delivery of proprietary educational ite
June 5, 2017	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2017 Commission File Number 000-30813 UMeWorld, Limited (Translation of registrant?s name into English) Suite 1504, 15/F, ISLAND CENTRE, 1 GREAT GEORGE STREET, CAUSEWAY BAY HONG
June 5, 2017	EX-99.1	Press Release umewfex991.htm
May 30, 2017	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2017 Commission File Number 000-30813 UMeWorld, Limited (Translation of registrant?s name into English) Suite 1504, 15/F, ISLAND CENTRE, 1 GREAT GEORGE STREET, CAUSEWAY BAY HONG K
May 30, 2017	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2017 AND SEPTEMBER 30, 2016 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2017 AND SEPTEMBER 30, 2016 (Unaudited) (All amounts in US Dollars) March 31, September 30, 2017 2016 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 22,349 $ 46,301 Accounts Receivable 341 265 Deposit 8,474 8,749 Prepayment 63,147 27,472 TOTAL CURRENT ASSETS 94,311 82,787 NON-CURRENT
May 30, 2017	EX-99.2	Mar 31 umewfex992.htm EXHIBIT 99.2 SECOND QUARTER 2017 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company?s K-12 flagship product, is a cloud-based, adaptive learning and assessment platform that can intelligently analyze and adapt to a student?s performance and personalizes the delivery of proprietary educational it
February 27, 2017	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2016 AND SEPTEMBER 30, 2016 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2016 AND SEPTEMBER 30, 2016 (Unaudited) (All amounts in US Dollars) December 31, September 30, 2016 2016 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 20,357 $ 46,301 Accounts Receivable 245 265 Deposit 8,406 8,749 Prepayment 37,561 27,472 TOTAL CURRENT ASSETS 66,569 82,787 NON-CU
February 27, 2017	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2017 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Ko
February 27, 2017	EX-99.2	Dec 31 umewfex992.htm EXHIBIT-99.2 FIRST QUARTER 2017 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company?s K-12 flagship product, is a cloud-based, patent-pending, adaptive learning and assessment platform that can intelligently analyze and adapt to a student?s performance and personalizes the delivery of proprietary
February 14, 2017	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2016 OR o Transition Report Pursuant to Section 13 or 15(d) of the Securities a
February 14, 2017	EX-13.1	Certification of Michael Lee pursuant to Section 1350 of Chapter 63 of Title 18 United States Code. EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
February 14, 2017	EX-12.2	Certification of Interim C.F.O. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
February 14, 2017	EX-13.2	Certification of Michael Lee pursuant to Section 1350 of Chapter 63 of Title 18 United States Code. EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Interim Chief Financial Officer of the Company, cert
February 14, 2017	EX-12.1	Certification of C.E.O. Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 30, 2017	NT 20-F	UMeWorld NT 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File No. 000-30813 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K x Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on
January 20, 2017	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month January 2017 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, C
August 31, 2016	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2016 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong
August 31, 2016	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2016 AND SEPTEMBER 30, 2015 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2016 AND SEPTEMBER 30, 2015 (Unaudited) (All amounts in US Dollars) June 30, September30, 2016 2015 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 49,823 $ 351,058 Accounts Receivable 275 262 Deposit 8,965 9,357 Prepayment 20,953 30,842 TOTAL CURRENT ASSETS 80,016 391,519 NON-CURRENT A
August 31, 2016	EX-99.2	THIRD QUARTER 2016 FINANCIAL RESULTS umewfex992.htm EXHIBIT-99.2 THIRD QUARTER 2016 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company?s K-12 flagship product, is a cloud-based, patent-pending, adaptive learning and assessment platform that can intelligently analyze and adapt to a student?s performance and personalizes the delivery of proprietary
May 31, 2016	EX-99.2	SECOND QUARTER 2016 FINANCIAL RESULTS umewfex992.htm EXHIBIT 99.2 SECOND QUARTER 2016 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company's K-12 flagship product, is a cloud-based, patent-pending, adaptive learning and assessment platform that can intelligently analyze and adapt to a student's performance and personalizes the delivery of proprietar
May 31, 2016	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2016 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant's name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, C
May 31, 2016	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2016 AND SEPTEMBER 30, 2015 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2016 AND SEPTEMBER 30, 2015 (Unaudited) (All amounts in US Dollars) March 31, September 30, 2016 2015 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 38,674 $ 351,058 Accounts Receivable 357 262 Deposit 9,225 9,357 Prepayment 28,526 30,842 TOTAL CURRENT ASSETS 76,782 391,519 NON-CURREN
May 5, 2016	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2016 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant's name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, C
May 5, 2016	EX-99.1	AWC (CPA) Limited umewfex991.htm EXHIBIT 99.1 AWC (CPA) Limited CERTIFIED PUBLIC ACCOUNTANTS 7/F, Nan Dao Commercial Building 359-361 Queen's Road Central Hong Kong Tel : (852) 2851 7954 Fax: (852) 2545 4086 May 5, 2016 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 We have read the statements concerning our firm contained in Form 6-K of UMeWorld Limited dated and filed with the Securi
February 29, 2016	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2015 AND SEPTEMBER 30, 2015 (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2015 AND SEPTEMBER 30, 2015 (Unaudited) (All amounts in US Dollars) December 31, 2015 September 30, 2015 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 172,140 $ 351,058 Accounts Receivable 260 262 Deposit 9,167 9,357 Prepayment 23,945 30,842 TOTAL CURRENT ASSETS 205,512 391,519 NO
February 29, 2016	EX-99.2	Dec 31 umewfex992.htm EXHIBIT 99.2 FIRST QUARTER 2016 FINANCIAL RESULTS General UMeWorld is an internet technology company with a focus on the K-12 education market in China. UMFun, the Company's K-12 flagship product, is a cloud-based, patent-pending, adaptive learning and assessment platform that can intelligently analyze and adapt to a student's performance and personalizes the delivery of proprietary
February 29, 2016	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2016 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant's name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Ko
January 29, 2016	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2015 OR o Transition Report Pursuant to Section 13 or 15(d) of the Securities a
January 29, 2016	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 29, 2016	EX-13.2	Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the "Company") on Form 20-F for the year ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael Lee, Interim Chief Financial Officer of the Company, cert
January 29, 2016	EX-13.1	Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the "Company") on Form 20-F for the year ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
January 29, 2016	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
August 28, 2015	EX-99.2	Jun 30, umewfex992.htm EXHIBIT 99.2 THIRD QUARTER 2015 FINANCIAL RESULTS General UMeWorld (the ?Company?) is an internet technology company with a focus on the education market in China. UMeWorld was originally incorporated in Delaware under its prior name AlphaRx Inc. in 1997. The Company was redomiciled to BVI and continued as a BVI registered company in January, 2013. On March 8, 2013, AlphaRx Inc. cha
August 28, 2015	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) umewf6k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2015 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong,
August 28, 2015	EX-99.1	UMEWORLD, LIMITED INTERIM CONSOLIDATED BALANCE SHEETS (All amounts in US Dollars) umewfex991.htm EXHIBIT 99.1 UMEWORLD, LIMITED INTERIM CONSOLIDATED BALANCE SHEETS (Unaudited) (All amounts in US Dollars) June 30, September 30, 2015 2014 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 481,133 $ 845,084 Accounts Receivable 462 440 Deposit 9,748 10,286 Prepayment 11,260 1,428 TOTAL CURRENT ASSETS 502,603 857,238 NON-CURRENT ASSETS Property, plant and equipment, ne
May 28, 2015	6-K	UMeWorld FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2015 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant?s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addres
May 28, 2015	EX-99.2	1 EXHIBIT 99.2 SECOND QUARTER 2015 FINANCIAL RESULTS General UMeWorld (the ?Company?) is an internet technology company with a focus on the education market in China. UMeWorld was incorporated in August 8, 1997 in Delaware under its prior name AlphaRx Inc. The Company was redomiciled to BVI and continued as a BVI registered company in January 7, 2013. On March 8, 2013, AlphaRx Inc. changed its name
May 28, 2015	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2015 AND SEPTEMBER 30, 2014 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2015 AND SEPTEMBER 30, 2014 (Unaudited) (All amounts in US Dollars) March 31, September 30, 2015 2014 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 568,012 $ 845,084 Accounts Receivable 396 440 Deposit 9,766 10,286 Prepayment 1,434 1,428 TOTAL CURRENT ASSETS 579,608 857,238 NON-CURRENT ASSETS Prope
February 27, 2015	6-K	UMEWF / UMeWorld Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month February 2015 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addre
February 27, 2015	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2014 AND SEPTEMBER 30, 2014 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2014 AND SEPTEMBER 30, 2014 (Unaudited) (All amounts in US Dollars) December 31, September 30, 2014 2014 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 708,793 $ 845,084 Accounts Receivable 390 440 Deposit 10,112 10,286 Prepayment 1,438 1,428 TOTAL CURRENT ASSETS 720,733 857,238 NON-CURRENT ASSET
February 27, 2015	EX-99.2	Dec 31 EXHIBIT 99.2 FIRST QUARTER 2015 FINANCIAL RESULTS General UMeWorld (the “Company”) is an internet technology company with a focus on the education market in China. UMeWorld was incorporated in August 8, 1997 in Delaware under its prior name AlphaRx Inc. The Company was redomiciled to BVI and continued as a BVI registered company in January 7, 2013. On March 8, 2013, AlphaRx Inc. changed its name t
February 20, 2015	6-K	UMEWF / UMeWorld Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month February 2015 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addre
January 30, 2015	20-F	UMEWF / UMeWorld Limited 20-F - - FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2014 OR ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities a
January 30, 2015	EX-13.2	Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.2 Certification by the Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lam, Interim Chief Financial Officer of the Company, cert
January 30, 2015	EX-12.1	Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lee, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 30, 2015	EX-12.2	Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.2 Certification by the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Michael Lam, certify that: 1. I have reviewed this annual report on Form 20-F of UMeWorld Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
January 30, 2015	EX-13.1	Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 EXHIBIT 13.1 Certification by the Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of UMeWorld Limited (the “Company”) on Form 20-F for the year ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Lee, Chief Executive Officer of the Company, certify, pur
August 29, 2014	EX-99.1	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED JUNE 30, 2014 EXHIBIT 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED JUNE 30, 2014 General UMeWorld (the “Company”) was incorporated in August 8, 1997 in Delaware under its prior name AlphaRx Inc. The Company was redomiciled to BVI and continued as a BVI registered company in January 7, 2013. On March 8, 2013, AlphaRx Inc. changed its
August 29, 2014	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2014 AND SEPTEMBER 30, 2013 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2014 AND SEPTEMBER 30, 2013 (Unaudited) (All amounts in US Dollars) June 30, September30, 2014 2013 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 893,903 $ 1,249,984 Accounts Receivable 10,073 162,539 Deposit 10,099 9,735 Prepayment 15,328 16,179 TOTAL CURRENT ASSETS 929,403 1,438,437 NON-CURRENT AS
August 29, 2014	6-K	UMEWF / UMeWorld Limited 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2014 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addr
May 30, 2014	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2014 AND SEPTEMBER 30, 2013 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2014 AND SEPTEMBER 30, 2013 (Unaudited) (All amounts in US Dollars) March 31, 2014 September 30, 2013 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 939,909 $ 1,249,984 Accounts Receivable 19,950 162,539 Deposit 9,713 9,735 Prepayment 15,682 16,179 TOTAL CURRENT ASSETS 985,254 1,438,437 NON-CURRENT
May 30, 2014	EX-99.2	Mar 31 EXHIBIT 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2014 General UMeWorld (the “Company”) was incorporated in August 8, 1997 in Delaware under its prior name AlphaRx Inc. The Company was redomiciled to BVI and continued as a BVI registered company in January 7, 2013. On March 8, 2013, AlphaRx Inc. changed its
May 30, 2014	20-F/A	- FORM 20-F/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A AMENDMENT NO. 2 (Mark One) o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2013 OR o Transition Report Pursuant to Section 13 or 15(d) o
May 30, 2014	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2014 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addr
March 3, 2014	EX-99.2	Dec 31 EXHIBIT-99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED DECEMBER 31, 2013 General UMeWorld (the “Company”) was incorporated in August 8, 1997 in Delaware under its prior name AlphaRx Inc. The Company was redomiciled to BVI and continued as a BVI registered company in January 7, 2013. On March 8, 2013, AlphaRx Inc. changed
March 3, 2014	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2014 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addr
March 3, 2014	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2013 AND SEPTEMBER 30, 2013 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT DECEMBER 31, 2013 AND SEPTEMBER 30, 2013 (Unaudited) (All amounts in US Dollars) December 31, September 30, 2013 2013 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 1,128,393 $ 1,249,984 Accounts Receivable 64,344 162,539 Deposit 9,795 9,735 Prepayment 15,465 16,179 TOTAL CURRENT ASSETS 1,217,997 1,438,437 NO
February 18, 2014	20-F/A	- FORM 20-F/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F/A AMENDMENT NO. 1 (Mark One) o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2013 OR o Transition Report Pursuant to Section 13 or 15(d) o
February 12, 2014	20-F	- FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o Registration Statement Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 OR x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2013 OR o Transition Report Pursuant to Section 13 or 15(d) of the Securities a
January 27, 2014	NT 20-F	- NT 20-F UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Washington, D.
August 19, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2013 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Add
August 19, 2013	EX-10.2	2013 Incentive Bonus Plan adopted July 1, 2013 (incorporated by reference to the Form 6-K filed on August 19, 2013) EXHIBIT 10.2 UMEWORLD LIMITED 2013 INCENTIVE BONUS PLAN Effective as of July 1, 2013 1. Purpose. The purpose of the UMeWorld Limited Incentive Bonus Plan (the "Plan") is to provide incentives to eligible management employees of UMeWorld Limited (the "Company") and any subsidiary to produce a superior return to the shareholders of the Company and to encourage such eligible management employees to r
August 19, 2013	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2013 AND SEPTEMBER 30, 2012 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT JUNE 30, 2013 AND SEPTEMBER 30, 2012 (Unaudited) (All amounts in US Dollars) JUNE 30, 2013 September 30, 2012 (Unaudited) (Audited) CURRENT ASSETS Cash and Cash Equivalents $ 1,230,997 $ 4,342 Accounts Receivable 255,553 108,982 Deposit 9,274 19,425,347 Prepayment 15,393 2,505 TOTAL CURRENT ASSETS 1,511,217 19,541,176 NON-CURR
August 19, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2013 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Add
August 19, 2013	EX-10.1	2013 Share Incentive Plan adopted July 1, 2013 (incorporated by reference to the Form 6-K filed on August 19, 2013) EXHIBIT 10.1 UMEWORLD LIMITED 2013 SHARE INCENTIVE PLAN (Adopted by the board of directors on July 1, 2013) ARTICLE 1 PURPOSE The purpose of the UMeWorld Limited Share Incentive Plan (the "Plan") is to promote the success and enhance the value of UMeWorld Limited an exempted company formed under the laws of the British Virgin Islands (the "Company") by linking the personal interests of the members
May 28, 2013	EX-99.1	UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2013 AND SEPTEMBER 30, 2012 (All amounts in US Dollars) EXHIBIT 99.1 UMEWORLD LIMITED INTERIM CONSOLIDATED BALANCE SHEETS AS AT MARCH 31, 2013 AND SEPTEMBER 30, 2012 (Unaudited) (All amounts in US Dollars) March 31, September 30, 2013 2012 CURRENT ASSETS (Unaudited) (Audited) Cash and Cash Equivalents $ 25,128 $ 4,342 Accounts Receivable 252,590 108,982 Deposit 19,425,347 19,425,347 Deferred Financing Cost 20,000 20,000 Prepayment 3,548 2,505 TOTAL CUR
May 28, 2013	EX-99.2	Mar 31, EXHIBIT 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2013 The following discussion should be read in conjunction with the information contained in the consolidated financial statements of the Company and the notes thereto appearing elsewhere herein and in conjunction with the Management's Discussion and Analys
May 28, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2013 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addres
May 24, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2013 Commission File Number 000-030813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addres
May 24, 2013	EX-99.3	Certificate of Name Change to UMeWorld Limited (incorporated by reference to the Form 6-K filed on May 25, 2013). EXHIBIT 99.3
May 24, 2013	EX-99.1	Amended Memorandum and Articles of Association of UMeWorld Limited (incorporated by reference to the Form 6-K filed on May 24, 2013). EXHIBIT 99.1
May 24, 2013	EX-99.2	1 EXHIBIT 99.2 1 2
April 18, 2013	EX-99.1	UMeWorld New Trading Symbol "UMEWF" to be Effective From April 18, 2013 EXHIBIT 99.1 UMeWorld New Trading Symbol "UMEWF" to be Effective From April 18, 2013 April 18, 2013 HONG KONG - (Marketwired - Apr 18, 2013) – UMeWorld Limited (OTCQB: ALRXF) - today announced that the company's new trading symbol "UMEWF" will become effective at the opening of trading on the OTC QB on April 18, 2013. The new trading symbol is the result of the company's new name, which was previo
April 18, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2013 Commission File Number 000-30813 UMeWorld, Limited (Translation of registrant’s name into English) 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay Hong Kong, China (Addre
April 15, 2013	EX-3.I(D)	Memorandum of Association and Articles of Association of AlphaRx, Inc., a BVI Corporation (incorporated by reference to the Form 8-K filed on April 15, 2013). EXHIBIT 3i(d)
April 15, 2013	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): April 12, 2013 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Emp
April 15, 2013	EX-3.I(E)	Certificate of Name Change to UMeWorld Limited (incorporated by reference to the Form 8-K filed on April 15, 2013). EXHIBIT 3i(e)
February 22, 2013	10-Q	Quarterly Report - FORM 10-Q alrx10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2012 OR o Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from:to Commission File Number: 000-030813 A
February 19, 2013	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): February 15, 2013 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S.
February 11, 2013	NT 10-Q	- NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report o
February 1, 2013	DEF 14C	- DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Definitive Information Statement AlphaRx, Inc. (Name of Registrant as Specified in Its Charter) Commission File Number: 000-030813 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay, Hong Kong (852) 2824-8716 (Address
January 22, 2013	PRE 14C	- PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Definitive Information Statement AlphaRx, Inc. (Name of Registrant as Specified in Its Charter) Commission File Number: 000-030813 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay, Hong Kong (852) 2824-8716 (Address
January 16, 2013	10-K	Annual Report - FORM 10-K alrx10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2012 o Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, I
December 27, 2012	NT 10-K	- NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report
August 31, 2012	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 29, 2011 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Em
August 31, 2012	EX-3.11	1 EXHIBIT 3.11 1 2 3 4 5 6 7 8 9
August 31, 2012	EX-10.11	ARTICLE I. Exchange of Shares EXHIBIT 10.11 AGREEMENT This AGREEMENT (this “Agreement”), dated as of August 29, 2012, is by and among AlphaRx, Inc., a Delaware corporation (the “Parent”), UMeLook Holdings Limited, a corporation formed pursuant to the laws of the British Virgin Islands (the “Company”), UMeLook Limited, a corporation formed pursuant to the laws of Hong Kong which is the wholly owned subsidiary of the Company (“U
August 31, 2012	EX-3.1	EX-3.1 EXHIBIT 3.1
August 13, 2012	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2012 OR o Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (N
May 8, 2012	10-Q	Quarterly Report - FORM 10-Q AlphaRx Inc.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2012 OR [] Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from
May 3, 2012	DEF 14C	- DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Definitive Information Statement AlphaRx, Inc. (Name of Registrant as Specified in Its Charter) Commission File Number: 000-030813 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay, Hong Kong (852) 2824-8716 (Address
May 3, 2012	EX-3.2	STATE OF DELAWARE EXHIBIT 3.2 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION AlphaRx, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: That by unanimous written consent in lieu of a special meeting of the Board of Directors of Alpha Rx, Inc., (the “Corporation”) resolut
April 30, 2012	CORRESP	- April 30, 2012 United States Securities and Exchange Commission Washington, D.C. 20549 Re: AlphaRx, Inc., PRE14C Filed April 23, 2012 File No. 000-30813 To whom it may concern: Please find our response to the comment of the Securities and Exchange Commission dated April 27, 2012 of the 14C for AlphaRx, Inc. SEC Comment 1 Principal Effects of the Reverse Stock Split Number of Shares of Common Stock
April 30, 2012	EX-3.2	FORM OF STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EX-3.2 2 alpharxex32.htm CERTIFICATE OF AMENDMENT EXHIBIT 3.2 FORM OF STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Alpha Rx, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: That by unanimous written consent in lieu of a special meeting of the Board
April 30, 2012	PRER14C	- AMENDED PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Amendment 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Preliminary Information Statement AlphaRx, Inc. (Name of Registrant as Specified in Its Charter) Commission File Number: 000-030813 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay, Hong Kong (852) 2824-
April 23, 2012	EX-3.2	FORM OF STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EXHIBIT 3.2 FORM OF STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Alpha Rx, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: That by unanimous written consent in lieu of a special meeting of the Board of Directors of Alpha Rx, Inc., (the “Corporation”
April 23, 2012	PRE 14C	- PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Preliminary Information Statement AlphaRx, Inc. (Name of Registrant as Specified in Its Charter) Commission File Number: 000-030813 31/F, Tower One, Times Square 1 Matheson Street, Causeway Bay, Hong Kong (852) 2824-8716 (Addres
February 7, 2012	10-Q	Quarterly Report - FORM 10-Q AlphaRx Inc.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2011 OR [] Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period f
December 9, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2011 [ ] Transition Report Pursuant to AlphaRx Inc.: Form 10-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2011 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to
September 6, 2011	EX-10.1	September 2, 2011 Exhibit 10.1 September 2, 2011 Grand Eastern Financial Group Limited 10/F, Miramar Tower, 132 Nathan Road Tsim Sha Tsui, Kowloon, Hong Kong Re: Financial Advisor for AlpahRx, Inc. Dear Mr. Loew: This letter sets forth the terms and conditions on which AlphaRx, Inc. (the "Company") has engaged Grand Eastern Financial Group (the ?Advisor?) for a period of 12 months from the date of this letter (the
September 6, 2011	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): September 2, 2011 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of incorporation or organ
August 22, 2011	EX-10.4	Promissory Note entered into by AlphaRx Canada Limited and Michael Lee on August 22, 2011 Exhibit 10.4 ALPHARX CANADA LIMITED SECURED PROMISSORY NOTE C$44,500 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Canada Limited, an Ontario corporation (the ?Company?), promises to pay to the order of Michael Lee, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place designated at any time by the Holder h
August 22, 2011	EX-10.6	Promissory Note entered into by the Company and AlphaRx International Holdings on August 22, 2011 Exhibit 10.6 ALPHARX INC. SECURED PROMISSORY NOTE US$19,594.02 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the ?Company?), promises to pay to the order of AlphaRx International Holdings, Inc, a British Virgin Islands company, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other pl
August 22, 2011	EX-10.9	Promissory Note entered into by the Company and Rita Sung on August 22, 2011 AlphaRx Inc.: Exhibit 10.9 - FIled by newsfilecorp.com Exhibit 10.9 ALPHARX INC. SECURED PROMISSORY NOTE C$10,000 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the “Company”), promises to pay to the order of Rita Sung, its successors and assigns (the “Holder”), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place desig
August 22, 2011	EX-10.10	Promissory Note entered into by the Company and Michael Lee on August 22, 2011 Exhibit 10.10 ALPHARX INC. SECURED PROMISSORY NOTE C$6,000 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the ?Company?), promises to pay to the order of Michael Lee, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place designated at any time by the Holder hereof, in lawful mon
August 22, 2011	EX-10.3	Promissory Note entered into by AlphaRx Canada Limited and First Scion Investments Limited on August 22, 2011 AlphaRx Inc.: Exhibit 10.3 - FIled by newsfilecorp.com Exhibit 10.3 ALPHARX CANADA LIMITED SECURED PROMISSORY NOTE C$542,974 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Canada Limited, an Ontario corporation (the “Company”), promises to pay to the order of First Scion Investments Limited, a British Virgin Islands company, its successors and assigns (the “Holder”), at 19/F, Two International Financ
August 22, 2011	EX-10.7	Promissory Note entered into by the Company and First Scion Investments Limited on August 22, 2011 Exhibit 10.7 ALPHARX INC. SECURED PROMISSORY NOTE US$43,000 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the ?Company?), promises to pay to the order of First Scion Investments Limited, a British Virgin Islands company, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place des
August 22, 2011	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): August 22, 2011 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Em
August 22, 2011	EX-10.1	Security Agreement dated August 22, 2011. Exhibit 10.1 SECURITY AGREEMENT This Security Agreement (?Agreement?) is made as of August 22, 2011 by and among AlphaRx, Inc., a Delaware corporation (the ?Debtor?), and the parties listed on Schedule A under heading Secured Parties (each a ?Secured Party?, and collectively the ?Secured Parties?). A. The Secured Parties have purchased and the Debtor and AlphaRx Canada Limited have issued secured
August 22, 2011	EX-10.5	Promissory Note entered into by the Company and AlphaRx International Holdings on August 22, 2011 Exhibit 10.5 ALPHARX INC. SECURED PROMISSORY NOTE C$95,000 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the ?Company?), promises to pay to the order of AlphaRx International Holdings, Inc, a British Virgin Islands company, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place
August 22, 2011	EX-10.8	Promissory Note entered into by the Company and First Scion Investments Limited on August 22, 2011 Exhibit 10.8 ALPHARX INC. SECURED PROMISSORY NOTE C$37,295 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Inc., a Delaware corporation (the ?Company?), promises to pay to the order of First Scion Investments Limited, a British Virgin Islands company, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong, or at such other place desi
August 22, 2011	EX-10.2	Promissory Note entered into by AlphaRx Canada Limited and AlphaRx International Holdings on August 22, 2011 Exhibit 10.2 ALPHARX CANADA LIMITED SECURED PROMISSORY NOTE C$584,313.99 August 22, 2011 FOR VALUE RECEIVED, AlphaRx Canada Limited, an Ontario corporation (the ?Company?), promises to pay to the order of AlphaRx International Holdings, Inc, a British Virgin Islands company, its successors and assigns (the ?Holder?), at 19/F, Two International Finance Centre , 8 Finance Street, Central, Hong Kong,
August 2, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2011 [_] Transition Report Pursuan AlphaRx, Inc.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2011 OR [] Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from
June 1, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): June 1, 2011 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identifica
June 1, 2011	EX-99.1	AlphaRx Terminates Its Chief Scientist and Chief Medical Officer for Cause AlphaRx Inc.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 AlphaRx Terminates Its Chief Scientist and Chief Medical Officer for Cause HONG KONG, June 1 /PRNewswire - AlphaRx Inc. (OTC BB:ALRX.OB) announced today that the Board of Directors of the Company has terminated Dr. Joseph Schwarz and Dr. Michael Weisspapir, the Chief Scientist and the Chief Medical Officer of the Company respectiv
May 13, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2011 [ ] Transition Report Purs UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2011 OR [ ] Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx,
February 14, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2010 [_] Transition Report Pur UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2010 OR [] Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx,
January 4, 2011	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (amendment no. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (amendment no. 1) [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2010 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-3081
January 3, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: September 30, 2010 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Nam
January 3, 2011	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-030813 [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 201
December 21, 2010	EX-16.1	Letter of SLF to the SEC dated December 20, 2010. Exhibit 16.1 December 20, 2010 Securities and Exchange Commission Office of the Chief Accountant 100 F Street, N.E. Washington, DC 20549 Re: AlphaRx, Inc. File No. 000-030813 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K of AlphaRx, Inc. and are in agreement with the statements contained in "Changes in Registrant's Certifying Accountant". We have no basis to agree or disagree with other
December 21, 2010	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): December 16, 2010 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Ident
August 23, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2010 [_] Transition Report Under Section UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2010 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Sm
August 16, 2010	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): AlphaRx Inc.: Form 12b-25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ x ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Peri
May 21, 2010	CORRESP	Ms. Ibolya Ignat, Staff Accountant AlphaRx Inc.: Correspondence Letter - Filed by newsfilecorp.com VIA EDGAR May 21, 2010 Ms. Ibolya Ignat, Staff Accountant Division of Corporation Finance United States Securities and Exchange Commission 101 F Street N.E. Washington, D.C. 20549 RE: AlphaRx Inc. Form 10K for the Fiscal Year Ended September 30. 2009 Form 10Q for the Quarterly Period Ended December 31, 2009 File No. 000-30813 Dear Ms.
May 19, 2010	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 17, 2010 Commission File N AlphaRx Inc.: Form 8-K/A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 17, 2010 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 9
May 18, 2010	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 17, 2010 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Emplo
May 14, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2010 [_] Transition Report Under Sectio AlphaRx, Inc.: Form 10-Q - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2010 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commis
March 15, 2010	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2009 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc
March 15, 2010	CORRESP	March 11, 2010 AlphaRx Inc.: Correspondence - Prepared by newsfilecorp.com March 11, 2010 Ms. Ibolya Ignat, Staff Accountant Division of Corporation Finance United States Securities and Exchange Commission 101 F Street N.E. Washington, D.C. 20549 RE: AlphaRx Inc. Dear Ms. Ignat; In response to your fax dated February 26, 2010, we hereby confirm that: Form 10–K for the Fiscal Year Ended September 30, 2009 Item 8A
March 15, 2010	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2009 [_] Transition Report Under Sec UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2009 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name o
February 12, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2009 [_] Transition Report Under Sec 10-Q 1 form10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2009 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000
December 4, 2009	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Q Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2009 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Nam
August 13, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2009 o Transition Report Under Section 13 AlphaRx, Inc.: Form 10-Q - Prepared by TNT Filings Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2009 OR o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commiss
May 15, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AlphaRx Inc.: Form 10-Q - Prepared by TNT Filings Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2009 OR o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commiss
February 13, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2008 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name o
December 23, 2008	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Q Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2008 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Nam
October 1, 2008	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 AlphaRx, Inc.: DEF 14A - Prepared by TNT Filings Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Q Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only [as per
August 14, 2008	10QSB	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Q Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2008 ¨ Transition Report Under Section 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Q Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2008 OR ? Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Sma
May 15, 2008	10QSB	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Q Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2008 ¨ Transition Report Under Section UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Q Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2008 OR ¨ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Sm
February 12, 2008	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Q Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2007 OR £ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: from to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Bu
December 31, 2007	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): December 28, 2007 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S.
December 31, 2007	EX-99.1	AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares Exhibit 99.1 AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares MARKHAM, ON, Dec. 28 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX - News), a leader in the development of Nanotechnology for Drug Delivery Platforms, announce that in order to meet TSX Venture Exchange listing requirements, its CEO, CFO, directors, consultants and employees plan to exercise stock opti
December 20, 2007	10KSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2007 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Name of Sma
November 29, 2007	8-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 14, 2007 Commission File Number: 000- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 14, 2007 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Ident
August 14, 2007	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2007 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Business
June 13, 2007	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 AlphaRx, Inc.: Schedule 14A - Prepared by TNT Filings Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission
May 16, 2007	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. May 14, 2007 Date of Report (Date of earliest event reported): AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 000-030813 98-0177440 (State or other jurisdiction of (Commission File Number: ) (I.R.S. Employer Identif
May 16, 2007	EX-99.1	AlphaRx and Proprius Pharmaceuticals Announce Top Line Results from Indaflex™ Phase II Study in Canada Exhibit 99.1 AlphaRx and Proprius Pharmaceuticals Announce Top Line Results from Indaflex? Phase II Study in Canada Monday, May 14, 2007 MARKHAM, Ontario and SAN DIEGO, California ? AlphaRx Inc. (OTCBB: ALRX) and Proprius Pharmaceuticals, Inc. today announced top line results from the Indaflex? 2.5% Topical Indomethacin Cream exploratory phase II clinical trial in osteoarthritis (OA) of the knee (
May 15, 2007	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2007 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Busines
March 20, 2007	CORRESP	/s/ Michael Lee Michael Lee, President and Chief Executive Officer /s/Marcel Urbanc Marcel Urbanc Chief Financial Officer and Principal Accounting Officer AlphaRx, Inc. 168 Konrad Crescent, Suite 200 Markham, Ontario, L3R 9T9 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 By FAX: (202) 772-9217 and by regular mail Re: Letter to AlphaRx Inc. dated March 8, 2007 March 17, 2007 Dear Madam; I am in receipt of your letter dated March 8, 2007 and subsequent fax corresponda
March 14, 2007	10KSB/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB/A [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2006 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Name of S
March 14, 2007	10QSB/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment 2) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 [_] Transition Report Under SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment 2) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Na
February 12, 2007	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 [_] Transition Report Under Section 13 or 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Busi
February 12, 2007	10QSB/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment 1) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 [_] Transition Report Under SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment 1) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2006 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Na
December 27, 2006	EX-99.1	AlphaRx Reports Fiscal 2006 Year End Results Exhibit 99.1 AlphaRx Reports Fiscal 2006 Year End Results Markham, Ontario, December 21, 2006 - AlphaRx Inc. (OTC Bulletin Board: ALRX), today reported financial results for the fiscal year ended September 30, 2006. "We are very pleased with the progress we have made in 2006, solidifying our R&D resources in the nanoparticle drug delivery platform, which has resulted in the recent signing of a Fea
December 27, 2006	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): December 21, 2006 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Ident
December 21, 2006	10KSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2006 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Name of Sma
November 9, 2006	8-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 7, 2006 Commission File Number: 000-0 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): November 7, 2006 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identi
November 9, 2006	EX-99.1	AlphaRx Signs Feasibility and Option Agreement with a Global Specialty Pharmaceutical Company for its Nanoparticle Drug Delivery Systems Exhibit 99.1 AlphaRx Signs Feasibility and Option Agreement with a Global Specialty Pharmaceutical Company for its Nanoparticle Drug Delivery Systems Tuesday November 07, 8:00 am ET Markham, Ontario – Nov 07, 2006 – AlphaRx Inc. (OTCBB: ALRX) announces the signing of a Feasibility and Option Agreement with a global pharmaceutical company based in U.S. Under the terms of the Agreement, AlphaRx will
August 14, 2006	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2006 [_] Transition Report Under Section 13 or 15(d) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2006 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Business
May 12, 2006	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2006 [_] Transition Report Under Section 13 or 15(d SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: March 31, 2006 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Busines
May 3, 2006	EX-99.1	AlphaRx Enters into Joint Venture Agreement with Leading Chinese Marketing Company To Distribute Its Proprietary Pharmaceutical and Consumer Product Lines Throughout Asia Exhibit 99.1 AlphaRx Enters into Joint Venture Agreement with Leading Chinese Marketing Company To Distribute Its Proprietary Pharmaceutical and Consumer Product Lines Throughout Asia Joint Venture Partner to Provide $31 Million in Funding; AlphaRx To Receive 30% Stake and 5% Royalty on Gross Sales Markham, Ontario, May 01, 2006 - AlphaRx Inc. (OTC Bulletin Board: ALRX), an emerging biopharmaceuti
May 3, 2006	8-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 1, 2006 Commission File Number: 000-030813 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): May 1, 2006 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identificat
April 19, 2006	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): April 10, 2006 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identifi
April 19, 2006	EX-99.1	AlphaRx and Proprius Pharmaceuticals Announce License Agreement for Indaflex™, a Phase II Topical NSAID for Osteoarthritis Exhibit 99.1 AlphaRx and Proprius Pharmaceuticals Announce License Agreement for Indaflex?, a Phase II Topical NSAID for Osteoarthritis Tuesday, April 11, 2006 MARKHAM, Ontario and SAN DIEGO, California - AlphaRx Inc. (OTCBB: ALRX) and Proprius Pharmaceuticals, Inc. today announced they have entered into a license agreement giving Proprius exclusive global rights (with the exception of Asia and Me
February 21, 2006	10QSB/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment No. 1) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2005 [_] Transition Report U SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A (Amendment No. 1) [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2005 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc.
February 14, 2006	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2004 [_] Transition Report Under Section 13 or 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: December 31, 2004 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Busi
February 7, 2006	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [X] Definitive Pro
January 25, 2006	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [ ] Definitive Pr
January 24, 2006	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14A of the SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ X] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only [as permitted by Rule 14a-6(e)(2)] [ ] Definitive Pr
December 29, 2005	10KSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2005 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Name of Sma
August 15, 2005	10QSB	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2005 [_] Transition Report Under Section 13 or 15(d) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended: June 30, 2005 OR [] Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from: to Commission File Number: 000-030813 AlphaRx, Inc. (Name of Small Business
August 15, 2005	POS AM	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 6 to SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ALPHARX, INC. (Name of Small Business Issuer in its Charter) Registration No. 000-30813 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 6 to SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ALPHARX, INC. (Name of Small Business Issuer in its Charter) Delaware 2834 98-0177440 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classificat
July 19, 2005	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): July 18, 2005 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identific
July 19, 2005	EX-99	AlphaRx Provides Update on Its Antibiotic Development Program Exhibit 99 AlphaRx Provides Update on Its Antibiotic Development Program Monday July 18, 8:00am ET MARKHAM, Ontario, July 18, 2005 - AlphaRx Inc.
July 14, 2005	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): July 14, 2005 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identific
July 13, 2005	EX-99	AlphaRx Receives Approval to Begin Phase II Clinical Trial For Indaflex™ Exhibit 99 AlphaRx Receives Approval to Begin Phase II Clinical Trial For Indaflex? Tuesday July 12, 8:00AM ET MARKHAM, Ontario, July 12, 2005 - AlphaRx Inc.
July 13, 2005	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): July 12, 2005 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identific
July 12, 2005	POS AM	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 5 to SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ALPHARX, INC. (Name of Small Business Issuer in its Charter) Registration No. 000-30813 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 5 to SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ALPHARX, INC. (Name of Small Business Issuer in its Charter) Delaware 2834 98-0177440 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classificat
July 11, 2005	CORRESP	AlphaRx Inc. AlphaRx Inc. 200-168 Konrad Crescent Markham, Ontario, Canada L3R 9T9 United States Securities and Exchange Commission Washington, D.C. 20549 RE: AlphaRx Inc. Post Effective Amendment to Form SB-2 filed May 19, 2005 File No. 333-118852 July 11, 2005 Dear Sirs; The Post Effective Amendment filed May 19, 2005 was filed just prior to AlphaRx being selected for review of its 10KSB for the year ended S
July 8, 2005	10KSB/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB/A [X] Annual Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the fiscal year ended: September 30, 2004 [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 for the transition period from to Commission File Number: 000-30813 AlphaRx, Inc. (Name of S
July 8, 2005	EX-10.2	MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 1st day of September, 2003, EX-10.2 2 mla.htm MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT AlphaRx Inc. - Manufacturing and Distributin License Agreement - Prepared By TNT Filings Inc. MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 1st day of September, 2003, BETWEEN: ALPHARX INC., a corporation incorporated under the laws of the State of Delaware, United States of America, and having its
June 29, 2005	8-K	Current Report SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): June 22, 2005 Commission File Number: 000-030813 AlphaRx, Inc. (Exact name of registrant as specified in its charter) Delaware 98-0177440 (State or other jurisdiction of (I.R.S. Employer Identific
June 29, 2005	EX-10.1	First Amendment to Manufacturing and Distribution License Agreement Exhibit 10.1 FIRST AMENDMENT TO "MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT" This First Amendment is dated 22nd June 2005, and is made between AlphaRx International Holdings Limited ("AIH"), a corporation incorporated under the laws of the British Virgin Islands, and having its principal place of business at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay, Hong Ko
June 28, 2005	EX-10.1	Press release of the Company dated December 16, 2004. Exhibit 10.1 AlphaRx Retains Patheon to Manufacture Clinical Materials Thursday December 16, 9:27 am ET MARKHAM, ON, Dec. 16 /CNW/ - AlphaRx Inc. (OTC BB:ALRX.OB - News), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, is pleased to announce that Patheon Inc., a leading provider of drug development and manufacturing servi
June 28, 2005	EX-10.2	Service Proposal Between Patheon Inc. and AlphaRx Inc. PATHEON PROPOSAL # : ALP-FTR1-0400-0504-R4 1. Parties: Patheon lnc.("Patheon") AlphaRx, Inc. ("Client") 2100 Syntex Court 200-168 Konrad Crescent Mississauga, Ontario L5N 7K9 Markham, ON L3R 9T9 Canada Canada 2. Product: Indaflex Cream (one strength) 3. Indication: Arthritis 4. Contract: This Proposal (including the Project Scope, Budget Summary, Standard Terms and Conditions for Pharmaceutical De

UMEWF / UMeWorld Limited - Depositi SEC, Relazione annuale, dichiarazione di delega

Statistiche di base

SEC Filings

SEC Filings (Chronological Order)